Cargando…
The Xu's chart for prostate biopsy: a visual presentation of the added value of biomarkers to prostate-specific antigen for estimating detection rates of prostate cancer
Elevated serum prostate-specific antigen (PSA) level is the primary indication for prostate biopsy for detection of prostate cancer (PCa) in the modern era. The detection rate of PCa from biopsy is typically below 30%, especially among patients with PSA levels at 4–10 ng ml(−1). In the past several...
Autor principal: | Xu, Jianfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4104076/ https://www.ncbi.nlm.nih.gov/pubmed/24625885 http://dx.doi.org/10.4103/1008-682X.125907 |
Ejemplares similares
-
Perspectives on the clinical management of localized prostate cancer
por: Nelson, Joel B
Publicado: (2014) -
Active surveillance for prostate cancer: when to recommend delayed intervention
por: Babaian, Kara N
Publicado: (2015) -
Therapy decisions for the symptomatic patient with metastatic castration-resistant prostate cancer
por: Markowski, Mark C, et al.
Publicado: (2015) -
Optimal management of prostate cancer with lethal biology – state-of-the-art local therapy
por: Chapin, Brian F
Publicado: (2015) -
Virtual Prostate Biopsy with Prostate-specific Membrane Antigen and Magnetic Resonance Imaging: Closer to Reality in a Subgroup of Prostate Cancer Patients?
por: Pomykala, Kelsey L., et al.
Publicado: (2022)